MENU
RLYB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rallybio (RLYB) Ownership - Who owns Rallybio?
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders... Show more
Profile
Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
43
Web
https://www.rallybio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.38M
P/E Ratio
N/A
Total Cash
65.51M
Projected Growth
N/A
Total Debt
154K
Revenue
636K
Risk (Beta)
-0.98
Dividend Yield
N/A
Total Cash/Share
1.57
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
RLYB
Capitalization
12.4M
P/E Ratio
N/A
Risk (Beta)
-0.98
Dividend Yield
N/A
Total Cash
65.5M
Total Cash/Share
1.57
Total Debt
154K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
636K
ROE
N/A
Book Value
61.7M
P/B Ratio
0.19
Cash Flow
N/A
Earnings
-1.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
10.87
Current Revenue Per Employee
1520.00
Dividends Per Share - Security
N/A
EBITDA
-60.37M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-62.89
Shares Held By Institutions
31.8M
Shares Outstanding - Current
41.6M
Total Liabilities
6.45M
Total Volume MTD
N/A
Value
1
Gain YTD
-69.000
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
43
Web
https://www.rallybio.com